Achieve High Cell Purity With The CTS DynaCellect Magnetic Separation System

A vital step in cell therapy development is isolating target T cells from white blood cells collected from a patient. The challenge at this stage of cell therapy development is isolating the right cells quickly and achieving high cell purity so the treatment can be produced and delivered quickly. Thermo Fisher Scientific worked with a customer that initially struggled to reach cell purity levels higher than 40%. Explore how the customer integrated the Gibco™ CTS™ DynaCellect™ Magnetic Separation System into their workflow to improve cell purity.